Terms: = Head and neck cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2
61 results:
1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, hk2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1.
Zhu G; Guan F; Li S; Zhang Q; Zhang X; Qin Y; Sun Z; Peng S; Cheng J; Li Y; Ren R; Fan T; Liu H
Mol Carcinog; 2024 May; 63(5):897-911. PubMed ID: 38353358
[TBL] [Abstract] [Full Text] [Related]
3. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract] [Full Text] [Related]
4. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
[TBL] [Abstract] [Full Text] [Related]
5. Bergenin Inhibits Tumor Growth and Overcomes Radioresistance by Targeting Aerobic Glycolysis.
Li X; Xie L; Zhou L; Gan Y; Han S; Zhou Y; Qing X; Li W
Am J Chin Med; 2023; 51(7):1905-1925. PubMed ID: 37646142
[TBL] [Abstract] [Full Text] [Related]
6. Increased levels of PD1 and glycolysis in CD4
Wu K; Han N; Mao Y; Li Y
BMC Oral Health; 2023 Jun; 23(1):356. PubMed ID: 37270478
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia-responsive lncRNA G077640 promotes ESCC tumorigenesis via the H2AX-HIF1α-glycolysis axis.
Huang X; Liu C; Li H; Dai T; Luo G; Zhang C; Li T; Lü M
Carcinogenesis; 2023 Aug; 44(5):383-393. PubMed ID: 37248865
[TBL] [Abstract] [Full Text] [Related]
8. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract] [Full Text] [Related]
9. Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo.
Fong LY; Huebner K; Jing R; Smalley KJ; Brydges CR; Fiehn O; Farber JL; Croce CM
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2220334120. PubMed ID: 37155893
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA DGCR5 Silencing Enhances the Radio-Sensitivity of Human Esophageal Squamous Cell Carcinoma via Negatively Regulating the Warburg Effect.
Wu J; Liu Y; Huang X; Cheng Y; Qian Z; Ni X; Chen S; Lin M; Luo J
Radiat Res; 2023 Mar; 199(3):264-272. PubMed ID: 36730936
[TBL] [Abstract] [Full Text] [Related]
11. Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma
Cai Y; Gao Q; Meng JH; Chen L
Nutr Cancer; 2023; 75(3):1028-1037. PubMed ID: 36718661
[TBL] [Abstract] [Full Text] [Related]
12. Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression.
Hei N; Liu P; Jin L; Peng S; Bao Y
Funct Integr Genomics; 2023 Jan; 23(1):52. PubMed ID: 36717528
[TBL] [Abstract] [Full Text] [Related]
13. SIRT3 Promotes the Development of Esophageal Squamous Cell Carcinoma by Regulating Hexokinase 2 through the AKT Signaling Pathway.
Yuan ML; Ren LH; Yu XC; Dong JW; Shi RH
Bull Exp Biol Med; 2022 Nov; 174(1):81-88. PubMed ID: 36437337
[TBL] [Abstract] [Full Text] [Related]
14. A pan-cancer analysis of the role of hexokinase II (hk2) in human tumors.
Li R; Mei S; Ding Q; Wang Q; Yu L; Zi F
Sci Rep; 2022 Nov; 12(1):18807. PubMed ID: 36335239
[TBL] [Abstract] [Full Text] [Related]
15. [
de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
[TBL] [Abstract] [Full Text] [Related]
16. Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.
Xie D; Hu G; Chen C; Ahmadinejad F; Wang W; Li PL; Gewirtz DA; Li N
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F322-F334. PubMed ID: 35834271
[TBL] [Abstract] [Full Text] [Related]
17. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract] [Full Text] [Related]
18. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
Long Y; Li C; Zhu B
Bioengineered; 2022 May; 13(5):13055-13069. PubMed ID: 35635053
[TBL] [Abstract] [Full Text] [Related]
19. HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Wang Y; Yu Z; Shi W; Shen J; Guan Y; Ni F
Bioengineered; 2022 Apr; 13(4):9301-9311. PubMed ID: 35389828
[TBL] [Abstract] [Full Text] [Related]
20. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.
Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z
Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537
[TBL] [Abstract] [Full Text] [Related]
[Next]
